<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-10-26T13:36:05+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.medicinanews.it/psicosi-postpartum-sistema-sanitario/369001/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-26T14:21:11+01:00</news:publication_date><news:title>Psicosi postpartum: quando il sistema sanitario non riconosce i segnali d&#8217;allarme</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/cliniche-longevita-medicina-preventiva/368998/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-26T13:21:16+01:00</news:publication_date><news:title>Le cliniche di longevità: come la medicina preventiva sta cambiando volto</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/uveite-non-infettiva-brepocitinib-roivant/368995/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-26T01:22:37+01:00</news:publication_date><news:title>Uveite non infettiva, il nuovo farmaco immunologico di Roivant amplia le opzioni terapeutiche</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/mappatura-prostata-tecnologie-diagnostiche/368992/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T19:39:10+02:00</news:publication_date><news:title>Mappatura precisa del tumore della prostata: le nuove tecnologie diagnostiche per stratificare il rischio</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/arbitri-no-profit-no-surprises-act-milioni/368989/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T18:39:12+02:00</news:publication_date><news:title>Gli arbitri indipendenti del No Surprises Act: come i mediatori sanitari accumulano milioni di dollari</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/divisione-salute-donne-nih-ricerca/368986/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T17:39:10+02:00</news:publication_date><news:title>La nuova divisione NIH sulla salute delle donne: come cambierà la ricerca medica</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/cancro-pancreatico-terapia-combinata-risultati/368983/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-24T15:38:08+02:00</news:publication_date><news:title>Cancro pancreatico avanzato: Tango Therapeutics riporta l&#8217;82% di risposta tumorale con la terapia combinata</news:title></news:news></url>
</urlset>
